Clinical trials
Immunization clinical trials
Below are recruiting immunization clinical trials, each written for real people, not researchers. We’re tracking 1,069 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06787560RecruitingEarly Phase 1
CAR-T cells and stem cell transplant for blood diseases
This trial tests a new approach for people with non-cancerous blood and immune system diseases. It uses your own engineered immune cells (CAR-T cells) to prepare your body for a stem cell transplant from a relative.
Hangzhou, ZhejiangAges Any age - NCT06792487Recruiting
Study of immune cells in psoriasis skin during anti-IL-23 treatment
This study looks at the immune cells in skin samples from people with psoriasis who are being treated with an anti-IL-23 biologic. The goal is to understand why some areas of skin do not improve or why flares happen, which may help improve treatments.
Rome, LazioAges 18 years+ - NCT06797024Recruiting
Study of JY231 injection for tough nerve immune disorders
This trial tests a new injection called JY231 for people with certain hard-to-treat nerve and immune disorders that haven't improved with standard treatments. It aims to see if this experimental therapy can help control the disease when other options have failed.
Wuhan, HubeiAges 18–75 - NCT06804135Recruiting
Immune response study during pelvic radiation for cervical cancer
This trial studies how the immune system responds to pelvic radiation therapy (with or without chemotherapy) in patients with cervical or other gynecologic cancers. It may help explain why some treatments work better and could lead to better treatments in the future.
Mumbai, MaharashtraAges 18 years+ - NCT06806137RecruitingPhase 3
Chickenpox vaccine study for healthy toddlers
This study tests how well a second dose of an investigational chickenpox vaccine works and how safe it is in healthy children. Your child would get the first dose between 12-15 months old, then a booster 3 months later.
Salvaleón de Higüey, La Altagracia ProvinceAges 1 year–1.3 years - NCT06807593RecruitingPhase 2
Treating ICI-related diarrhea or colitis with ustekinumab
This trial tests if ustekinumab can help cancer patients who have diarrhea or colitis caused by immune checkpoint inhibitors. It may be an option if standard treatments haven't worked or aren't suitable.
Houston, TexasAges 18 years+ - NCT06809868Recruiting
Study of genetic elements in sepsis and aging
This trial looks at how certain genetic elements may affect the immune system in older adults with sepsis. It aims to understand why older patients may respond differently to severe infections.
San Francisco, CaliforniaAges 18 years+ - NCT06810934RecruitingPhase 1/Phase 2
New COVID-19 vaccine study for those with prior mRNA vaccines
This study tests a new type of COVID-19 vaccine that is designed to train your immune system to make stronger, longer-lasting protection. You may be able to join if you are 40–64, have already had at least two doses of a mRNA COVID-19 vaccine (Pfizer or Moderna) more than 4 months ago, and are generally healthy.
Los Angeles, CaliforniaAges 40–64 - NCT06815029RecruitingPhase 1
Modified immune cells for recurrent brain cancer
This trial tests a new treatment using your own immune cells that are genetically modified to find and attack brain tumor cells. It is for people with a type of brain cancer that has come back after standard therapy.
Duarte, CaliforniaAges 18 years+ - NCT06817408Recruiting
Organ Damage and Immune Exhaustion in Sepsis
This study looks at how sepsis (a severe infection) affects organs and the immune system over time. It may help find better ways to treat people who have had a septic shock.
Rochester, MinnesotaAges 18 years+ - NCT06818149Recruiting
Studying heart inflammation from immunotherapy in lung cancer
This study looks for specific markers in the blood that can help doctors better understand and treat heart inflammation (myocarditis) caused by immunotherapy in people with lung cancer. If you join, you will help find ways to improve care for other patients.
ShanghaiAges 18 years+ - NCT06821958Recruiting
Radio wave treatment for advanced liver cancer
This trial tests a new type of treatment using low-energy radio waves (called electromagnetic fields) for people with advanced liver cancer that can't be removed by surgery. The goal is to see if adding this therapy can help your immune system fight the cancer better.
BerlinAges 18 years+ - NCT06826066Recruiting
How your immune system reacts to radiation therapy
This study looks at how your immune system affects how your body reacts to radiation therapy. It involves a blood sample and is for people who have had radiation but no major side effects.
Créteil, Île-de-France RegionAges 18 years+ - NCT06826430RecruitingPhase 1
CAR-T cell therapy for severe lupus-related low platelets
This trial tests a new CAR-T cell treatment called Inaticabtagene Autoleucel for people with lupus that causes very low platelet counts (immune thrombocytopenia) that hasn't gotten better with standard treatments. The goal is to see if it can help raise platelet levels.
Beijing, Beijing MunicipalityAges 18–70 - NCT06828458Recruiting
Immune response to fungus in burn patients
This study looks at how the immune system fights fungus after a burn. It may help doctors understand which patients are at higher risk for infection and how to better protect them.
ParisAges 18 years+ - NCT06833957Recruiting
Preparing for a maternal GBS vaccine in Africa
This study is preparing for future trials of a vaccine for Group B Strep (GBS) in pregnant women. It includes different parts: watching pregnant women and their babies, surveying GBS infections, and understanding how communities feel about vaccines.
Mariakani, CoastAges Any age - NCT06839456RecruitingPhase 1/Phase 2
Stem cell addback to prevent infections after transplant
This trial tests whether adding back certain immune cells after a stem cell transplant can help prevent serious viral or fungal infections. It's for children and young adults up to age 25 who need a transplant for a blood cancer or other curable disease.
Philadelphia, PennsylvaniaAges 1 month–25 years - NCT06841913RecruitingPhase 4
Woodsmoke, flu, and your nasal immune response
This study tests how breathing woodsmoke affects your nose's ability to fight off the flu virus. You will be exposed to woodsmoke and then given a live flu vaccine to see how your immune system responds.
Chapel Hill, North CarolinaAges 18–49 - NCT06852287RecruitingPhase 2
Study of chemo, targeted therapy, and immunotherapy for bile duct and gallbladder cancer
This trial tests a combination of chemotherapy directly to the liver, a targeted therapy pill, and an immunotherapy drug for people with advanced bile duct or gallbladder cancer that cannot be surgically removed. The goal is to see if this triple therapy can shrink or control the cancer.
Tianjin, TiaAges 18 years+ - NCT06855160RecruitingPhase 3
Chickenpox & MMR Vaccine Study for Healthy Toddlers
This study tests a new chickenpox vaccine combined with a standard MMR vaccine (measles, mumps, rubella) in healthy children aged 12-15 months. The goal is to see how well the vaccines work and how safe they are when given as a shot in the arm.
Tucson, ArizonaAges 1 year–1.3 years - NCT06855706Recruiting
Personalized physical activity program for ovarian and endometrial cancers
This study tests whether a personalized, automated physical activity program (using a Fitbit and continuous glucose monitor) can improve immune function and health outcomes in people with advanced ovarian, primary peritoneal, fallopian tube, or newly diagnosed endometrial cancer. You'll wear an activity tracker, answer questionnaires, and provide blood and stool samples at Roswell Park.
Buffalo, New YorkAges 18 years+ - NCT06858683Recruiting
Time-restricted eating study for people with obesity
This study tests if eating only within a certain time window each day can improve immune function in people with obesity who are planning bariatric surgery. You would follow a time-restricted eating plan for 10-12 weeks before your surgery to see how it affects your health.
BarcelonaAges 18–64 - NCT06859424RecruitingPhase 2
Testing a new GVHD prevention method after donor stem cell transplant
This trial tests a new way to prevent graft-versus-host disease (a common side effect of stem cell transplant) using a drug called cyclophosphamide after transplant. It is for adults with certain blood cancers who need a transplant from a partially matched unrelated donor.
Birmingham, AlabamaAges 18–66 - NCT06862843Recruiting
Family eating habits and chronic inflammation study
This study looks at how eating habits and family health history relate to chronic inflammatory conditions like Crohn's disease, ulcerative colitis, and juvenile idiopathic arthritis. It aims to understand these links by studying families with a child or adult affected by these conditions, as well as healthy families.
Florence, ItalyAges Any age
Hear when a new Immunization trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for immunization?
- Yes. Clin2 currently lists 1,069 recruiting immunization studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a immunization trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a immunization trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.